Joseph Edelman – ELVN history

Issuer:
ENLIVEN THERAPEUTICS INC
Quarters tracked:
1 (Q3 2026 → Q3 2026)
Current shares:
462,506
Current value:
$21.20M
Peak shares:
462,506 (Q3 2026)
Overall change:
0%
QuarterSharesValue$/ShareShare ΔΔ%
Q3 2026462,506$21.20M$45.84—NEW